AARTIDRUGS — Aarti Drugs Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹35.59bn
- IN₹41.12bn
- IN₹25.65bn
Annual cashflow statement for Aarti Drugs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | R2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2,700 | 2,242 | 2,355 | 2,118 | 2,109 |
| Depreciation | |||||
| Non-Cash Items | 204 | 348 | 316 | 286 | 358 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,707 | -1,760 | 404 | -515 | -601 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 696 | 1,333 | 3,589 | 2,446 | 2,535 |
| Capital Expenditures | -1,520 | -1,648 | -2,263 | -1,772 | -1,733 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 31.1 | 8.46 | 26.8 | 125 | -0.9 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,489 | -1,640 | -2,237 | -1,646 | -1,734 |
| Financing Cash Flow Items | -344 | -362 | -446 | -468 | -323 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 920 | 165 | -1,360 | -821 | -774 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 128 | -141 | -7.61 | -21.7 | 26.9 |